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inding of insulin to the -subunit of the human insulin receptor (HIR) induces rapid tyrosine phosphorylation of the insulin receptor -s u b u n i t . Insulin-stimulated tyrosine phosphorylation occurs at 6 tyrosine residues, the tyrosines 1146/50/51 in the kinase domain, the tyrosines 1316 and 1322 in the COOH-terminal tail of the receptor -subunit, and tyrosine 960 in the juxtamembrane region. Numerous studies have demonstrated that, in particular, the phosphorylation of the 3 tyrosines in the kinase domain is essential for further signal transduction on the postreceptor level (1) . Recently, it was shown that these tyrosines are also important for the interaction with the kinase receptor ligand binding domain of insulin receptor substrate (IRS)-2 (2). The phosphorylation of tyrosine in the juxtamembrane region appears to be important for docking protein binding through their phosphotyrosine-binding domains (3) . The rapid insulin-stimulated tyrosine phosphorylation of the receptor -subunit is followed by a somewhat slower increase of serine and threonine phosphorylation of the receptor -subunit (1). Even t h o u g h insulin-induced serine/threonine phosphorylation was described for the first time in 1982 (4), the signific a n c e of serine/threonine phosphorylation of the receptor is still not understood. A number of serine/threonine phosphorylation sites in the -subunit were identified. Sites proposed to be phosphorylated upon stimulation by protein kinase C (PKC) include the following: threonine 1336 (5), serine 1293/94 (6), serine 1315 (7), serine 1309 (8) , and serine 1023/25 (9) . Insulin-stimulated serine phosphorylation appears to occur on serines 955/56 in the juxtamembrane region (10, 11) . The functional significance of these serine-phosphorylated domains is not clear. One potential function is the inhibition of insulin receptor tyrosine kinase activity, which leads to impaired insulin signaling. This hypothesis is based on studies in which it was shown that PKC stimulation by phorbolesters or hyperglycemic conditions (12) and transfection of cells with PKC isoforms , , , , and may reduce insulin receptor tyrosine autophosphorylation or insulin-dependent tyrosine phosphorylation of downstream elements of the insulin-signaling chain (12) (13) (14) . IRS-1 phosphorylation at serine residues also seems to be involved in the inhibitory effect of some PKC isoforms ( , , and ) on the insulin receptor. Whereas serine phosphorylation of IRS-1 by PKC leads to an apparent molecular weight shift of IRS-1, an analogous shift for the insulin receptor has not been demonstrated (14) . It is therefore still unknown whether serine phosphorylation of the receptor by PKC occurs in relevant quantities and whether it is required for inhibition of the receptor. We have used 16 serine mutants of HIR as well as a COOH-terminal deletion to study the importance of kinase inhibition after treatment of cells by 2-deoxyglucose (15) . None of the serine sites seemed to be required for the 2-deoxyglucose-dependent inhibition of the receptor (16) . We also have used these constructs to define whether any of the serine residues are required for PKC-dependent receptor inhibition in a cotransfection system in human embryonic kidney (HEK) 293 cells. In this study, HIR994 and HIR1023/25 showed an impaired inhibition by PKC-2 and PKC-, suggesting that these domains are important for the inhibitory effect of PKC on the insulin receptor (16a). It remains to be determined whether this effect involves phosphorylation of these domains by PKC or whether these domains are important for the inhibitory interaction with serine-phosphorylated IRS-1.
In addition to a potential function of serine phosphorylation for negative receptor modulation, a role in downstream signaling is another possible function. The aim of the present study was to determine the significance of the serine phosphorylation sites for downstream signaling. Our data show that the HIR1177/78/82 mutant exhibits an altered interaction with the substrates IRS-1, IRS-2, and ( S H C ) Src homologous and collagenl i k e, but is not impaired in its autophosphorylation capacity.
RESEARCH DESIGN AND METHODS

M a t e r i a l s.
Cell culture reagents and fetal calf serum (FCS) were purchased from Gibco (Egenstein, Germany); culture dishes were from Greiner (Frickenhausen, Germany). Porcine insulin, aprotinin, phenylmethylsulfonyl fluoride, Na 3 V O 4 , Triton X-100, and dithiotreitol were from Sigma (Munich). The reagents for SDS-PAGE and Western blotting were from Roth (Karlsruhe, Germany) and Bio-Rad (Munich). Protein A sepharose CL 4B was from Pharmacia (Uppsala, Sweden). Nitrocellulose was from Schleicher & Schuell (Dessel, Germany). All other reagents were from the best grade commercially available. A polyclonal antibody recognizing the insulin receptor -subunit was raised against the COOH-terminal 15 amino acids of the receptor. Monoclonal anti-phosphotyrosine antibody (PY20) was purchased from Leinco Technologies (St. Louis, MO), and a polyclonal antibody directed against the extracellular domain of the insulin receptor and suitable for blotting was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Monoclonal antibody 83-14 directed against the extracellular domain of HIR was a generous gift from Ken Siddle (Cambridge, U.K.). The polyclonal rabbit antibodies against IRS-1 and IRS-2 and the cDNA for IRS-1, IRS-2, and SHC were a generous gift from M.F. White (Joslin Diabetes Center, Boston, MA). Vi s u a l i z ation of proteins after Western blotting was performed using the nonradioactive enhanced chemiluminescence system and Hyperfilm from Amersham-Pharmacia Biotech (Freiburg, Germany). [ - 3 2 P ] ATP and [ 3 2 P]orthophosphate were obtained from NEN-DuPont (Bad Homburg, Germany). Recombinant IRS-1 was from Upstate Biotechnology (Lake Placid, NY). Preparation of serine-to-alanine point mutants of the insulin receptor. All point mutations were prepared by the method of Kunkel et al. (17) in the cytomegalovirus immediate early promoter-based vector pRK5 (18) containing the cDNA sequence for the wild-type human insulin receptor. The mutagenic oligos are as follows: serine 1023/25: (19) . Briefly, cells were grown in 6-well dishes at a density of 3 1 0 5 cells per well in 2 ml of medium. A total of 4 µg supercoiled plasmid DNA was mixed with 0.25 mol/l CaCl 2 in a final volume of 0.1 ml. To this, an equal amount of 2 transfection buffer (50 mmol/l N,N-bis[2-hydroxyethyl]-2-aminothansulfonic acid, pH 6.95, 280 mmol/l NaCl, 1.5 mmol/l Na 2 H P O 4 ) was added, and after incubation for 10 min at room temperature, the mixture was given dropwise to the cells. After incubation for 16 h at 37°C and 3% CO 2 , the cells were serum starved for 24 h in Dulbecco's modified Eagle's medium (1 g/l glucose) containing 0.5% FCS. Generation of recombinant retroviruses. The cDNAs for HIR and the different mutants were cloned into the H p aI site of the retroviral expression vector pLXSN (20) . To prepare retroviral stocks by transient transfection (21) , HEK 293 cells were cotransfected with each of these constructs and a packaging -r e t r oviral vector (a gift from Dr. Dan R. Littman). The titer of the recombinant retroviruses was determined after infection of NIH3T3 cells with serial dilutions of retrovirus-containing cell-free supernatants. Titers were in the range of 1-3 1 0 5 infectious units/ml. Retrovirus-mediated gene transfer. One million NIH3T3 cells per 10-cm dish were incubated with supernatants of HEK 293 cells containing the recombinant retroviruses for 12 h at 37°C, 5% CO 2 , and in the presence of 8 µg/ml polybrene. Virus-containing medium was then removed, and cells were grown in medium containing 750 µg/ml geneticin. After 2-3 weeks of selection, at least 12 single clones were picked per infection and analyzed for the expression level of the transduced gene. Stimulation with insulin, cell lysis, and immunoprecipitation. Serumstarved cells were stimulated with or without 10 -7 mol/l insulin for 5 min at 37°C and lysed in 0.2 ml per 10 c m 2 dish of ice-cold lysis buffer (50 mmol/l HEPES, pH 7.5, 150 mmol/l NaCl, 1.5 mmol/l MgCl 2 , 1 mmol/l EGTA, 10% glycerol, 1% Tr i t o n X-100, 1 mmol/l phenylmethylsulfonyl fluoride, 10 µg/ml aprotinin, 100 mmol/l NaF, 1 0 mmol/l Na 4 P 2 O 7 , and 2 mmol/l Na 3 V O 4 ). Crude lysates were cleared by centrifugation (20 min/12,000g) and analyzed on SDS-PAGE (40 µg protein per lane) or used for immunoprecipitations. For immunoprecipitations, 200 µl crude lysates were diluted with the same volume of immunoprecipitation buffer ( 5 0 mmol/l HEPES, pH 7.5, 0.1% Triton X-100, 150 mmol/l NaCl, 10% glycerol, and 2 mmol/l Na 3 V O 4 ), combined with 30 µl protein A sepharose and antiserum, and rotated overnight at 4°C. Immunoprecipitates were washed 3 times with 1 ml wash b u f f e r, boiled for 5 min in 1 Laemmli buffer, and separated by 7.5% SDS-PA G E . Western blotting. After SDS-PAGE, proteins were transferred to nitrocellulose membranes by semidry blotting (transfer buffer: 20 mmol/l NaH 2 P O 4 , 20 m m o l / l N a 2 H P O 4 , pH 8.8). After transfer, filters were blocked with NET-G buffer ( 1 5 0 mmol/l NaCl, 5 mmol/l EDTA, 50 mmol/l TRIS, 0.05% Triton X-100, and 0.25% gelatine, pH 7.4) for 1 h. Subsequently, filters were incubated with the first antibody overnight at 4°C. The membranes were washed 3 times with NET-G buffer before they were incubated with peroxidase-conjugated anti-mouse or anti-rabbit IgG for 1 h at room temperature. Visualization of immunocomplexes was performed by enhanced chemiluminescence. Phosphatidylinositol 3-kinase assay. Phosphatidylinositol 3-kinase (PI 3-kinase) assays were performed as described by Morgan et al. (22) , with some m o d i fications. Briefly, IRS-1 was immunoprecipitated from NIH3T3 cell lysates as described above. Immunoprecipitates were washed twice in phosphatebuffered saline, 1% Nonidet-P40, and 100 µmol/l Na 3 V O 4 ; twice in 500 mmol/l LiCl, 100mmol/l Tris/Cl (pH 7.5), and 100mmol/l Na 3 VO 4 ; and twice with 10mmol/l Tris/Cl (pH 7.5), 100mmol/l NaCl, 1mmol/l EDTA, and 100µmol/l Na 3 VO 4 . The beads were resuspended in 25 µl of 60 mmol/l Tris/Cl (pH 7.5), 300 m m o l / l NaCl, 12mmol/l MgCl 2 and 12.5 µl phosphatidylinositol (1mg/ml). The kinase reaction was started by adding 12.5 µl of 40 µmol/l ATP containing 10 µCi [ -32 P]ATP, and samples were incubated for 20 min at room temperature. The reaction was stopped by addition of 150 µl 1N HCl. Lipids were extracted once with 450 µl chloroform:methanol (1:1, vol/vol), and the phospholipid-containing organic phase was resolved on thin-layer chromatography plates (Silica Gel 60; Merck, Darmstadt, Germany) and developed in chloroform:methanol:aceton:glacial acetic acid:water (40:13:15:12:7, vol/vol). Thin-layer chromatography plates were dried and exposed on Kodak (Rochester, NY) X-AR 5 film. Insulin receptor kinase activity. HEK 293 fibroblasts were stimulated with insulin, and cell lysates were prepared and added to microwells coated with anti-HIR antibody. After the receptor had bound to the antibody, wells were washed, and kinase activity was measured in the presence of 0.3 µ m o l / l [ - 3 2 P ] ATP (100-200 Ci/mmol) and 2.4 µg/ml recombinant IRS-1. Wells were then washed again, and insulin binding activity (defined as the amount of insulin s p e c i fically bound at 8.7 nmol/l) was analyzed as previously described (23) . In vivo 3 2 P-labeling, isolation, tryptic digestion, and high-performance liquid chromatography phosphopeptide analysis of the insulin receptor. HEK 293 cells were plated in 100-mm dishes, transfected with the cDNA of HIR or HIR1177/78/82 as described above, and serum starved for 15 h. For [ 3 2 P ] -l a b e ling, cells were incubated for 2 h in phosphate-and serum-free RPMI 1640 medium and then maintained in phosphate-free RPMI 1640 containing 0 . 5 mCi/ml [ 3 2 P]orthophosphate for 2 h. After insulin stimulation (5 min, 1 0 0 nmol/l), incubation was stopped by placing the cells on ice followed by 1 wash with ice-cold phosphate-buffered saline. Cells were lysed, and the insulin receptors were isolated by immunoprecipitation with 83-14 antibody and separated by SDS-PAGE as outlined above. After visualization of the phosphorylated -subunit by autoradiography, the band was cut from the gel, reduced (dithiothreitol), and alkylated (4-vinylpyridine) before tryptic digestion.
The following high-performance liquid chromatography separation of the phosphopeptides was carried out with a SunChrom high-performance liquid chromatography (HPLC) system (SunChrom, Friedrichsdorf, Germany) using a TSK Gel Super-ODS 120 0 . 3 mm capillary column (Grom, Herrenberg, Germany) at a flow rate of 5 µl/min. The mobile phase consisted of water with 0.05% trifluoroacetic acid (solvent A) and acetonitrile:water:trifluoroacetic acid (80:10:0.075, solvent B). The phosphopeptides were eluted by a stepwise acetonitrile gradient from 5% solvent B (20 min) to 45% solvent B within 90 min, to 95% solvent B within 50 min and again 95% solvent B for 10 min. Fractions were collected at 2-min intervals in 0.2 ml polymerase chain reaction tubes, and the radioactivity was measured as Cerenkov radiation using an AmershamPharmacia Biotech scintillation counter.
R E S U LT S
We have previously reported that a mutation of several serine residues to alanine in HIR does not lead to a signific a n t change in receptor autophosphorylation. This is in contrast to the mutation of serine residues 994 and 1023/25, which increased autophosphorylation or a 12-amino acid deletion in the juxtamembrane that showed a reduced autophosphorylation capacity. To investigate the potential of the different mutants to tyrosine phosphorylate HIR substrates, we used a transient expression system and transiently overexpressed the wild-type HIR or its mutants together with IRS-1 in 293 cells. After the cells were made quiescent, they were stimulated with insulin as indicated in Fig. 1 and then lysed. Aliquots of the total cell lysates were run on SDS-PAGE, and proteins were transferred to nitrocellulose and blotted with phosphotyrosine antibodies. Cells transfected with IRS-1 alone revealed a weak autophosphorylation of the endogenous HIR -s u b u n i t after insulin stimulation (second lane in Fig. 1 ) and a strong phosphorylation of a 180-kDa protein. This protein does not represent the overexpressed IRS-1, since it has a lower apparent molecular weight on the gel and is also found in cells not overexpressing IRS-1 (second lane in Fig. 4 ). It may therefore represent IRS-4, which is abundant in these cells. Co-overexpression of HIR and IRS-1 yielded a -subunit autophosphorylation that was partly insulin independent. Ty r o s i n e phosphorylation of IRS-1 was very strong and mostly insulin independent, indicating that the low insulin-independent activity of HIR was sufficient for full phosphorylation of I R S-1. At around 200 kDa, a tyrosine-phosphorylated protein was found that represents an unprocessed HIR precursor that also is autophosphorylated constitutively. Co-overexpression of the HIR JM or the HIR1177/78/82 mutant and IRS-1 gave a similar result but showed overall reduced amounts of substrate phosphorylation, whereas the other serine-to-alanine mutations and COOH-terminal deletion mutant did not lead to a reduced tyrosine phosphorylation of IRS-1. The presence of similar amounts of HIR and IRS-1 was v e r i fied by stripping the antibodies from the filters and reprobing with the appropriate antisera.
To investigate more specifically the phosphorylation on IRS-1, the residual lysates of some of the transfections shown in Fig. 1 were used for immunoprecipitation. The immunoprecipitates were analyzed as above, and the results are presented in Fig. 2 . Again, HIR mutants with the juxtamembrane deletion or the serine mutations 1177/78/82 were not or were only partly capable of phosphorylating IRS-1. The capability of the HIR1177/78/82 mutant to phosphorylate IRS-2 is demonstrated in Fig. 3 . Similar to the previous experiments, 293 cells transiently overexpressed either HIR or HIR1177/78/82 together with IRS-1 or IRS-2. Cells were stimulated with insulin as indicated, lysed, and immunoprecipitated with the appropriate antibodies. As shown in F i g . 3A, the mutant HIR had a reduced phosphorylation capability not only for IRS-1, but also for IRS-2. The presence of similar amounts of overexpressed IRS-1 or IRS-2 is demonstrated in the lower panel of Fig. 3A , while Fig. 3B shows the autophosphorylation and amount of HIR and the mutant.
Another important substrate of HIR is the adapter protein SHC, which was also analyzed for tyrosine phosphorylation in this system (Fig. 4) . When overexpressed in 293 cells, SHC was not phosphorylated by the endogenous HIR but was strongly and constitutively tyrosine phosphorylated when co-overexpressed with HIR. Furthermore, SHC was also phosphorylated by the COOH-terminal deletion mutant and most of the serine-to-alanine mutants of HIR but not the juxtamembrane deletion or the HIR1177/78/82 mutant. The overexpression of the proteins encoded by the transfected plasmids was verifie d by reblotting the filter with antibodies against SHC and HIR. We conclude that in addition to IRS-1 and IRS-2, SHC is also phosphorylated to a lesser extent by the HIR1177/78/82 mutant in the transient overexpression system.
Because transient overexpression systems may pose problems in the specificity of protein-protein interactions, we next tried to repeat our results in established cell lines. We transfected NIH3T3 cells with expression plasmids encoding either the wild-type HIR or the mutants with a juxtamembrane deletion or serine exchanges. Cell colonies were isolated and tested for the expression of the transfected HIR type, and clones with similar expression levels were selected. In addition, a pool of HIR1177/78/82 overexpressing 3T3 cells was also established. The different cell lines were grown to confluence, stimulated with insulin or left untreated, lysed, and endogenous IRS-1 immunoprecipitated and analyzed for tyrosine phosphorylation, as described previously. The fil t e r was then tested for the presence of similar amounts of IRS-1 ( F i g . 5, lower panel). As shown in the upper panel, in established cell lines, the phosphorylation of IRS-1 was strictly dependent on insulin stimulation and was much reduced in cell lines overexpressing the juxtamembrane deletion mutant or HIR1177/78/82 but not wild-type HIR or other serine mutants.
Because a reduced phosphotyrosine content of IRS-1 should lead to a reduced association of the regulatory subunit of the PI 3-kinase, we evaluated the associated amount of PI 3-kinase in our cell lines. Again, cells were grown to confluence and stimulated with insulin, lysed, and IRS-1 immunop r e c i pi t a t e d . The PI 3-kinase activity was determined in the 
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immunoprecipitate in an in vitro assay (Fig. 6A) . Clearly, the insulin signal through the wild-type HIR produced a much stronger response than the juxtamembrane deletion or the HIR1177/78/82 mutants. To quantify this observation, we analyzed 4 independent experiments by scanning densitometry and set the PI 3-kinase activity in insulin-stimulated wildtype HIR transfected cells as 100% (Fig. 6B) . Stimulation of the mutated receptor HIR1177/78/82 led to a signific a n t l y reduced PI 3-kinase activity that associates with IRS-1 (60% of HIR wild-type, P = 0.003). These results indicate that the insulin receptors behaved similarly in the transient expression system and in established cell lines and that the HIR1177/78/82 mutant was not capable of mediating a full insulin response.
Although the HIR1177/78/82 mutant could autophosphorylate to a similar extent as the wild-type receptor, the phosphorylation of 3 different substrates was impaired. We therefore asked whether low substrate kinase activity is a general feature of the mutation and performed an in vitro kinase a s s a y. Wild-type HIR and HIR1177/78/82 mutant were transiently overexpressed in 293 cells, and the cells were stimulated with insulin or left untreated, lysed, and subjected to the assay using recombinant IRS-1. As shown in Fig. 7 , the mutant receptor was unable to phosphorylate IRS-1 to a signific a n t extent. Therefore, the kinase of HIR1177/78/82 is capable of producing a normal signal for autophosphorylation but cannot transmit the insulin signal efficiently.
F i n a l l y, we addressed the question of whether the phosphorylation pattern of the mutated receptor is different from the wild-type insulin receptor. Therefore, we performed in vivo labeling studies in which the metabolically [ where the major insulin-stimulated phosphate incorporation occurs. In Fig. 8B , the HPLC profiles after insulin stimulation of the wild-type HIR and the HIR1177/78/82 mutant are compared. Insulin stimulation led to an identical phosphopeptide pattern of both receptor proteins. Thus, we conclude that substitution of serines did not change the 3 2 P incorporation into any of the peptides of the regulatory loop.
D I S C U S S I O N
In the present study, we have investigated the effects of serine to alanine mutations on the signaling of HIR. We have identified serine residues 1177/78/82 as dispensable for receptor autophosphorylation but required for substrate phosphorylation. In 3 different experimental systems, i.e., transient expression, established cell line, and in vitro, the mutant receptor was not capable of phosphorylation of HIR substrates or initiating events further downstream but was responsive to insulin and fully autophosphorylated. Furthermore, the in vivo labeling studies suggest that the autophosphorylation cascade of the mutated receptor is u n c h a n g e d .
Several mutations in the intracellular part of the -s u b u n i t of HIR have been described that were found in diabetic patients (25) . Most of these mutations affect both autophosphorylation and the substrate phosphorylation and thus have a general effect on the kinase activity. Cocozza et al. (26) have described the exchange of Arg 1152 to Gln, which is still capable of autophosphorylation but not of in vitro substrate phosphorylation. In other studies, however, this mutant receptor was described to be impaired in autophosphorylation and to have a high constitutive kinase activity (27) . Therefore, it is not clear whether this mutant is similar to HIR1177/78/82.
Like the mutations with a general effect on kinase, the exchanged Arg 1152 residue lies in a region that is important for catalytic activity, whereas the serine mutations used in this study are found COOH-terminally of the activation loop (28) . Nevertheless, serine 1178 is conserved in tyrosine kinases and supposed to stabilize the kinase structure (28) . It is therefore conceivable that the mutation of serine 1178 is the one that is causal for the impaired substrate phosphorylation and that this mutation interferes with substrate phosphorylation. A computer search for possible consensus sites for serine/threonine phosphorylation revealed that serine 1177 is a putative target for casein kinase 2 (CK-2). This finding creates the possibility that phosphorylation of serine 1177 could interfere with the suggested hydrogen binding of serine 1178 to threonine 1175 and thus also destabilize the kinase. Experiments are ongoing to investigate whether CK-2 can phosphorylate this residue of HIR and whether this phosphorylation has an effect on substrate phosphorylation.
From our in vivo labeling experiments, we conclude that the phosphorylation of all major phosphopeptides is identical and that the serine substitutions have no influence on the autophosphorylation cascade. Furthermore, we suggest that 1177, 1178, and 1182 are not major phosphorylation sites, since we could not detect any phosphopeptide in wild-type HIR lost in the HIR1177/78/82 preparations. However, it is still possible that these sites are minor phosphorylation sites that were not detectable by this experimental approach. The decreased signal capacity of HIR1177/78/82 might therefore be due to an impaired phosphate transfer to its substrate.
In conclusion, we have identified a new type of mutation in HIR that permits autophosphorylation but interferes with substrate phosphorylation.
